News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,823 Results
Type
Article (42847)
Company Profile (297)
Press Release (681678)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (210582)
Career Advice (2095)
Deals (36672)
Drug Delivery (107)
Drug Development (83161)
Employer Resources (175)
FDA (16649)
Job Trends (15441)
News (356419)
Policy (33997)
Tag
Academia (2600)
Accelerated approval (10)
Adcomms (23)
Allergies (101)
Alliances (51579)
ALS (113)
Alzheimer's disease (1465)
Antibody-drug conjugate (ADC) (161)
Approvals (16647)
Artificial intelligence (330)
Autoimmune disease (30)
Automation (19)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (129)
Biotechnology (188)
Bladder cancer (93)
Brain cancer (38)
Breast cancer (370)
Cancer (2925)
Cardiovascular disease (224)
Career advice (1758)
Career pathing (31)
CAR-T (188)
CDC (32)
Cell therapy (509)
Cervical cancer (22)
Clinical research (68436)
Collaboration (1049)
Company closure (3)
Compensation (699)
Complete response letters (29)
COVID-19 (2697)
CRISPR (63)
C-suite (338)
Cystic fibrosis (117)
Data (3035)
Decentralized trials (2)
Denatured (30)
Depression (64)
Diabetes (350)
Diagnostics (6511)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (143)
Drug pricing (135)
Drug shortages (31)
Duchenne muscular dystrophy (131)
Earnings (89176)
Editorial (42)
Employer branding (21)
Employer resources (151)
Events (116651)
Executive appointments (867)
FDA (18338)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (946)
Gene editing (138)
Generative AI (24)
Gene therapy (392)
GLP-1 (827)
Government (4631)
Grass and pollen (5)
Guidances (182)
Healthcare (19024)
HIV (40)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (158)
Immuno-oncology (10)
Indications (40)
Infectious disease (2870)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (122)
Interviews (323)
IPO (16869)
IRA (51)
Job creations (4064)
Job search strategy (1494)
Kidney cancer (13)
Labor market (53)
Layoffs (519)
Leadership (20)
Legal (8401)
Liver cancer (80)
Longevity (12)
Lung cancer (407)
Lymphoma (211)
Machine learning (11)
Management (59)
Manufacturing (408)
MASH (93)
Medical device (13551)
Medtech (13556)
Mergers & acquisitions (20522)
Metabolic disorders (875)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (121)
Neuropsychiatric disorders (34)
Neuroscience (2168)
NextGen: Class of 2025 (6642)
Non-profit (4536)
Now hiring (47)
Obesity (444)
Opinion (242)
Ovarian cancer (102)
Pain (120)
Pancreatic cancer (122)
Parkinson's disease (188)
Partnered (22)
Patents (308)
Patient recruitment (170)
Peanut (53)
People (59689)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21229)
Phase II (30113)
Phase III (22548)
Pipeline (1660)
Policy (215)
Postmarket research (2654)
Preclinical (9059)
Press Release (68)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (483)
Real estate (6268)
Recruiting (68)
Regulatory (23516)
Reports (50)
Research institute (2375)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (94)
Series A (161)
Series B (110)
Service/supplier (12)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3739)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (63)
The Weekly (59)
Vaccines (802)
Venture capital (54)
Weight loss (276)
Women's health (47)
Worklife (16)
Date
Today (75)
Last 7 days (349)
Last 30 days (1884)
Last 365 days (31683)
2025 (17155)
2024 (35771)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (783)
Alabama (61)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (41120)
Australia (6569)
California (7498)
Canada (2380)
China (696)
Colorado (323)
Connecticut (321)
Delaware (195)
Europe (87870)
Florida (1128)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (654)
India (28)
Indiana (370)
Iowa (17)
Japan (236)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1036)
Massachusetts (5614)
Michigan (248)
Minnesota (455)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2098)
New Mexico (29)
New York (2104)
North Carolina (1103)
North Dakota (8)
Northern California (3295)
Ohio (237)
Oklahoma (16)
Oregon (39)
Pennsylvania (1626)
Puerto Rico (17)
Rhode Island (36)
South America (1164)
South Carolina (35)
South Dakota (1)
Southern California (2807)
Tennessee (126)
Texas (1137)
United States (27903)
Utah (222)
Virginia (198)
Washington D.C. (72)
Washington State (643)
West Virginia (4)
Wisconsin (69)
724,823 Results for "astex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies
April 24, 2025
·
3 min read
Genetown
Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting
Astex Pharmaceuticals announced that it will make five key data presentations at AACR 2024 focusing on its Phase II-ready MDM2 antagonist, ASTX295.
April 3, 2024
·
3 min read
Biotech Bay
Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting
Taiho Oncology Inc. and Astex Pharmaceuticals, Inc. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 9-12, 2023, in San Diego.
November 17, 2023
·
5 min read
Press Releases
Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium
October 21, 2024
·
4 min read
Genetown
Astex Expands Drug Discovery Collaboration With MSD
Astex Pharmaceuticals announced an exclusive worldwide research collaboration and license agreement with MSD.
August 8, 2023
·
2 min read
Policy
Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. announce that the European Commission has approved INAQOVI® as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia who are ineligible for standard induction chemotherapy.
September 19, 2023
·
7 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 10, 2025
·
3 min read
Press Releases
Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
1 of 72,483
Next
